This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Diving into Dexcom Inc's G7 and ONE app data-display inconsistencies and management approaches for diabetic patients relying on CGM

Ticker(s): DXCM

Who's the expert?

Institution: Yale School of Medicine

  • Assistant Professor at Yale University in the Section of Endocrinology
  • Manages over 100+ patients annually with Type 2 Diabetes and Obesity
  • Possesses additional training in obesity medicine and weight management; Research focus involves the comprehensive management of the interrelated disease processes of diabetes, obesity, and sleep disorders.

Interview Questions
Q1.

Roughly how many diabetes patients requiring CGM do you manage monthly? 

Added By: dami_admin
Q2.

What are some of the common challenges you see patients face when using tech-based solutions for glucose monitoring

Added By: dami_admin
Q3.

What are your overall thoughts on the growing role of digital tools in diabetes care and how they shape patient outcomes?

Added By: dami_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.